
PBS Biotech secures $17 million in follow-on round

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio closes $80 million Series C financing round
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. A2 Bio is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. Proceeds Read More →
805 Tech: Region’s investments in AI will continue paying off

Let’s get this out of the way now. If you got tired of hearing about artificial intelligence and how it is going to revolutionize our way of life, well, fair warning, that isn’t going to stop in 2025. In fact, that’s probably the majority of tech trends you’re going to hear about — and the Central Read More →

Will the region’s top stocks keep dominating in 2025?

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne completes $58M takeover of Micropac

Thousand Oaks-based Teledyne Technologies completed its acquisition of Micropac Industries on Dec. 30. The all-cash transaction valued Micropac at approximately $57.3 million, taking into account Micropac’s net debt as of Aug. 24. Under the merger agreement’s terms, Micropac stockholders received $20 per share in cash. “We are delighted to welcome Micropac and its employees to Read More →